Cantourage Group (HIGH) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
23 Jun, 2026Executive summary
Revenue for H1 2025 was €823,447.73, down from €898,038.78 in H1 2024, mainly from related-party service contracts.
Net income for H1 2025 was €36,168.96, a decrease from €210,989.14 in H1 2024.
Operating expenses included higher legal, consulting, and regulatory costs compared to the prior year.
Financial highlights
Total assets as of June 30, 2025, were €45,473,615.85, nearly unchanged from €45,476,315.99 a year earlier.
Equity stood at €44,372,852.12, with a slight decrease from €44,468,380.10 year-over-year.
Cash and cash equivalents were €3,484,218.00 at period end.
Bilanzgewinn (retained earnings) was €154,138.93, down from €249,666.91.
Outlook and guidance
No significant unrecognized financial obligations exist as of June 30, 2025.
Patronatserklärung (letter of comfort) for APSAT GmbH extends until December 31, 2027, ensuring financial support.
Latest events from Cantourage Group
- Net profit surged to €210,989.14 in H1 2024, driven by higher revenue and one-time income.HIGH
H1 202423 Jun 2026 - Revenue and net income grew strongly, with all earnings retained and a clean audit opinion.HIGH
H2 202423 Jun 2026 - Q1 2025 revenue soared to EUR 25.6 million, quadrupling year-over-year on robust European demand.HIGH
Q1 2025 TU23 Jun 2026 - Profitable, asset-light cannabis platform drives growth with innovation and telemedicine.HIGH
Investor presentation23 Jun 2026 - Q2 2025 revenue more than doubled year-over-year, exceeding last year's total annual sales.HIGH
Q2 2025 TU23 Jun 2026 - Revenue up 148% year-over-year to EUR 75 million, with strong growth and European expansion plans.HIGH
Q3 2025 TU23 Jun 2026 - Revenue up 78% to €3.9M, net income €126K, audit unqualified, all sales intra-group.HIGH
H2 202523 Jun 2026 - Q1 2026 saw higher profitability, strong UK growth, and a robust financial position.HIGH
Q1 2026 TU23 Jun 2026